Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.
about
Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Inhibition of the Receptor Tyr ...... vity in Uterine Serous Cancer.
@en
Inhibition of the Receptor Tyr ...... vity in Uterine Serous Cancer.
@nl
type
label
Inhibition of the Receptor Tyr ...... vity in Uterine Serous Cancer.
@en
Inhibition of the Receptor Tyr ...... vity in Uterine Serous Cancer.
@nl
prefLabel
Inhibition of the Receptor Tyr ...... vity in Uterine Serous Cancer.
@en
Inhibition of the Receptor Tyr ...... vity in Uterine Serous Cancer.
@nl
P2093
P2860
P1476
Inhibition of the Receptor Tyr ...... vity in Uterine Serous Cancer.
@en
P2093
Andrea R Hagemann
Carolyn K McCourt
David G Mutch
Emily Schepers
Ian S Hagemann
Jeanne M Quinn
Kelsey Reger
Marguerite L Palisoul
Matthew A Powell
P2860
P304
P356
10.1158/1535-7163.MCT-17-0587
P577
2017-09-13T00:00:00Z